Compare ADMA & IOSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | IOSP |
|---|---|---|
| Founded | 2004 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | 2012 | 1998 |
| Metric | ADMA | IOSP |
|---|---|---|
| Price | $10.69 | $74.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $28.00 | ★ $124.00 |
| AVG Volume (30 Days) | ★ 9.5M | 253.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | ★ 228.87 |
| EPS | 0.60 | ★ 4.67 |
| Revenue | $42,219,783.00 | ★ $1,778,000,000.00 |
| Revenue This Year | $27.46 | $5.96 |
| Revenue Next Year | $22.11 | $6.10 |
| P/E Ratio | $17.49 | ★ $16.09 |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $7.21 | $65.51 |
| 52 Week High | $25.67 | $95.55 |
| Indicator | ADMA | IOSP |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 52.57 |
| Support Level | $7.21 | $70.89 |
| Resistance Level | $16.30 | $76.78 |
| Average True Range (ATR) | 0.61 | 2.01 |
| MACD | 0.29 | 0.66 |
| Stochastic Oscillator | 97.74 | 63.11 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.